12-15 May 2025
Congress Center Hamburg, GermanyHamburg, GermanyKey Sessions
Nicole Borth
KEYNOTE: Heterogeneity and What Makes a Phenotype
BOKU University and Austrian Center of Industrial Biotechnology (ACIB)
Andreas Laustsen
Using Monoclonal Antibodies as Antivenom
Technical University of Denmark
Adam Goldstein
Optimising Bioprocessing for Environmental Sustainability: The Power of Process Intensification
Thermo Fisher Scientific
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day One - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Formats
08:00 - 08:55
Welcome Coffee and Registration
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
08:55 - 09:00
Chairperson's Opening Remarks: Cell Line Development & Engineering
09:00 - 09:30
KEYNOTE: Heterogeneity and What Makes a Phenotype
- Nicole Borth - Department of Biotechnology, , BOKU University and Austrian Center of Industrial Biotechnology (ACIB)
09:30 - 10:00
Label-Free LC-MS/MS Characterization of the Ubiquitin-Modified Proteome of Recombinant Chinese Hamster Ovary Cells in Response to ER-Stress in Bioprocess-Relevant Conditions
- Paula Meleady - Associate Professor, School of Biotechnology, Dublin City University
10:00 - 10:30
Quantitative Synthetic Biology to Advance Biologics Production
- Mark Stockdale - Senior Director, Strategic Alliance, Asimov
08:55 - 09:00
Chairperson Opening Remarks: Cell Culture & Upstream Processing
- Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
09:00 - 09:30
Metabolism-driven Precision Biomanufacturing of cellular Therapeutics
- Sakis Mantalaris - Don Panoz Chair of Pharmaceutical Biology, Trinity College Dublin
09:30 - 10:00
Holistic approach to modulation of recombinant protein quality
- Matjaž Brinc - Associate Director Science & Technology in Biologics Drug Substance Development, Novartis
10:00 - 10:30
Intensified Production of Recombinant Vesicular Stomatitis Virus-Based Vectors by Tangential Flow Depth Filtration
- Béla Brühlmann - Field Application Scientist Upstream, Repligen
08:55 - 09:00
Chairperson's Opening Remarks: Recovery & Purification
- Stefano Menegatti - Associate Professor, North Carolina State University
09:00 - 09:30
ML Driven Controls for Bioprocessing
- Massimo Morbidelli - Emeritus Professor, Department of Chemistry and Applied Biosciences, ETH Zurich
09:30 - 10:00
Next Generation Downstream Process Development and Manufacturing
- Fabian Vogt - Head of Laboratory, Protein Science, Boehringer Ingelheim Pharma GmbH & Co. KG
10:00 - 10:30
Trends and challenges in sterile filtration of high concentration drugs
- Mike Collins - Senior Director R & D, Cytiva
08:55 - 09:00
Chair’s Welcome Remarks: Manufacturing Strategy & Bioprocessing 4.0
- Jose Ortiz Tena - Manager Lead Bioprocess Optimization, Roche
09:00 - 09:30
Deploying Modeling & Simulation to Enable Advanced Process Monitoring & Control
- Johannes Scheiblauer - Head of Automation & Control (R&D PharmSci), Takeda
09:30 - 10:00
Paradigm shift in Biologics manufacturing – to cope with challenges in New Biologics Modality manufacturing
- Uwe Buecheler - Senior Advisor Biopharmaceuticals and Former SVP, Head of Business Unit Biopharmaceuticals, Boehringer Ingelheim
10:00 - 10:30
Principles and platform ability of fiber chromatographic clarification technology from discovery to manufacturing
- Masa Nakamura - Bioprocess Science Senior Specialist, 3M Health Care
08:55 - 09:00
Chair’s Welcome Remarks: Cell and Gene Therapy Manufacturing
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
09:00 - 09:30
Developing ATMPs for commercialization: A large Pharma process approach from idea to a manufactured Cell Therapy product
- Michael Delahaye - Director of Cell Therapy BioProcessing: Cell Therapy, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca
09:30 - 10:00
VSV-GP process development
- Michaela Smolle - Principal Scientist, Bioprocess Innovation Team, ViraTherapeutics
10:00 - 10:30
Please move to another track
Showing 2 of 2 Streams
Break
Sustainability Spotlight
10:30 - 11:15
Morning Break in Foyers
10:35 - 11:05
Optimising Bioprocessing for Environmental Sustainability: The Power of Process Intensification
- Adam Goldstein - Sr. Director, R&D Innovation, Thermo Fisher Scientific
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
11:15 - 11:45
KEYNOTE: Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production
- James Budge - Postdoctoral Research Fellow, University of Kent
11:45 - 12:15
Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales
- Sara Rodriguez Conde - Associate Director, AstraZeneca
12:15 - 12:45
Evaluation of StreamLink® CC 15 for Clone Selection: a Novel Benchtop System for automated sample preparation in Ambr® Cell Line Development Workflows
- João Henrique Santos - Scientist, DSP Department, Polpharma Biologics
- James Edwards - Global Product Manager, Sartorius
11:15 - 11:45
Digital Twins Using Real-Time and Genome Data
- Dong-Yup Lee, Ph.D. - Associate Professor, School of Chemical Engineering at Sungkyunkwan University
11:45 - 12:15
Digital twin predictions of cell expansion in a perfusion bioreactor for autologous CAR-T cell therapy
- Joseph Egan - Research Fellow in Mathematical Modelling of Cell and Gene Therapies, University College London
12:15 - 12:45
Data-driven process intensification - utilizing smart analytics to achieve your bioprocess goals
- Nick Randall - Bioprocessing Product Manager, 908 Devices
11:15 - 11:45
Digital Twins and Hybrid Models for Bioprocess Intensification and Optimization
- Krist V. Gernaey - Professor, Technical University of Denmark
11:45 - 12:15
Application of Modelling Tech in BLA
- Joey Studts, Ph.D. - Director, Late Stage Purification Development, Boehringer Ingelheim Pharma GmbH & Co. KG
12:15 - 12:45
Enhancing Efficiency and Quality in mAb Production: Innovative Solutions for Harvesting and Impurity Removal
- Andreas Jordan - Field Applications Scientist, Thermo Fisher Scientific
- Michael Andesner - Staff Scientist, Field Applications, Purification, Thermo Fisher
11:15 - 11:45
Bioprocessing strategies for multi-national trials: Streamlining clinical success through bioprocess decision-making
- Ben Weil - Director of Manufacturing, INmune Bio
11:45 - 12:15
Using analytics to support AAV manufacturing strategies
- Fiammetta Di Marco - Post Doctoral Researcher, Center for Proteomics and Metabolomics, Leiden University Medical Center
12:15 - 12:45
Usage of the ProCellics™ Raman Analyzer in mRNA Manufacturing
- Laurens Vergauwen - Process Development Scientist, Merck Life Science BV
11:15 - 11:45
Applying continuous integrated processing for cell and gene therapies
- Manuel Carrondo - Vice-President, Instituto de Biologia Experimental e Tecnológica
11:45 - 12:15
Strategic development of bioprocessing platforms for the scalable manufacturing of allogeneic stem cell therapies
- Ricardo Baptista - Chief Technology Officer, Independent
12:15 - 12:30
Affordable Bioprocessing for Viral Vectors
- Pim Velthof, PhD - Senior Bioprocess Scientist USP, Batavia Biosciences BV
12:30 - 12:45
AAV capsid analysis with mass photometry in cGMP regulated environments
- Jan Schaeferkordt - Technical Sales Manager, Refeyn
Showing 2 of 2 Streams
Networking Break
Live Labs
12:45 - 14:10
Grand Opening of the Exhibition Hall and Lunch
13:20 - 13:30
Nova Biomedical Live Lab: Fully Automated Cell Density and Cell Viability Analysis
The new BioProfile® FAST CDV by Nova Biomedical is a High Throughput, Fully Automated Cell Density and Cell Viability Analysis. The analyzer is capable of producing results in under 82 seconds with just 100uL of sample volume. In addition, it performs all sample dilutions internally, enabling cell culture samples up to 140e6 c/mL to be analyzed without any external sample dilution. Come and have a demonstration of the new FAST CDV Analyzer at Stand #152.
13:30 - 13:40
Thermo Fisher Scientific Live Lab: Maximize Product Recovery in Fill Finish
13:40 - 13:50
Cytiva Live Lab: Supor™ Prime sterilizing grade filters
13:50 - 14:00
Sartorius Live Lab: Sartorius Scalable Solutions
14:00 - 14:10
BioRad Laboratories Live Lab: Explore Bio-Rad Process Chromatography Products, Services and Support to Advance the Production of Biologics
Showing 5 of 5 Streams
Cell Line Development & Engineering
Cell Culture & Upstream Processing
Recovery & Purification
Manufacturing Strategy & Bioprocessing 4.0
Cell and Gene Therapy Manufacturing
14:10 - 14:15
Chairperson Remarks
- Anne Tolstrup - CEO, AbtBioConsult ApS
14:15 - 14:45
Engineering Mammalian Cell Growth Dynamics for Biomanufacturing
- Mauro Torres Sebastian - Research Associate, University of Manchester
14:45 - 15:15
KEYNOTE: Look before you leap: Use of digital tools for clone selection and optimisation of novel quality assessments to enable efficiencies in Cell Line Development
- Robyn Emmins - Scientific Director, Cell Line Development, GSK
15:15 - 15:45
Streamlining Cell Line Development Processes with Automated High-Throughput Antibody Analytics
- Eligio Iannetti - Senior Business Development Manager, Beckman Coulter Life Sciences
- Peter Braun - Application Specialist, Beckman Coulter Life Sciences
14:10 - 14:15
Chairperson Remarks
- Wolfgang Sommeregger - CEO, QUBICON AG
14:15 - 14:45
New Cell Culture Analyser Technology at Large Scale: Case study of implementation, issues and resolution
- Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
14:45 - 15:15
Raman-based monitoring of the amino acids and the antibody N-glycosylation in high cell density steady-state perfusion culture
- Veronique Chotteau, PhD - Professor in mammalian-based bioprocessing, KTH - Royal Institute of Technology
15:15 - 15:45
Media development and Process Optimization for Increased AAV titer.
- Sünje Fischer - Technical Application Consultant – Upstream Processing, Merck
14:10 - 14:15
Chairperson Remarks
14:15 - 14:45
Chelation Technology, A Simple and Effective Solution to Remove Copper from CSL's Human Albumin Product
- Dominique Zemp - Scientist Process Development, CSL Behring AG Bern
14:45 - 15:15
The Need for Seamless Data Management, Data Contextualization and Data Analysis to Ensure Data Integrity & Data Maturity
- Christoph Herwig - Fr. Professor for Biochemical Engineering Senior Scientific Advisor, Körber Pharma Austria GmbH
15:15 - 15:45
Process Intensification using connected process for Purification of mAbs: PD to Scale Up for Robust, Cost Effective, and Agile Manufacturing
- Sanket Jadhav, PhD - External Collaborations Manager (Global), Sartorius
14:10 - 14:15
Chairperson Remarks
14:15 - 14:45
Implementation of Automated Manufacturing and Advanced Sensoring
- Karoline Bechtold-Peters - Director, Science & Technology, Novartis
14:45 - 15:15
Fed Batch Intensification with PAT To Improve the Efficiency and Productivity of Biologics Manufacturing
- David Valentine - Associate Director, Global MSAT, Lonza Biologics
15:15 - 15:45
Filling the Gap Between Downstream & Fill-Finish with Scalable Single-Use Technologies
- Alexandre Monzo - Head of Sales EMEA, Single Use Support GmbH
14:10 - 14:15
Chairperson Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:15 - 14:45
Empowering Process Development for Viral Vector-Based Medicines
- Dieter Palmberger - CTO, bespark*bio
14:45 - 15:15
Expanding the manufacturing solutions for cell and gene therapies
- Adam Brown, Ph.D. - Associate Professor of Biopharmaceutical Engineering; CTO, University of Sheffield
15:15 - 15:45
Viral safety aspects of biological raw materials used to manufacture biologics including advanced therapy medicinal products
- Kerstin Brack - Scientific Director, Global Biosafety, Charles River
15:45 - 16:25
Afternoon Break in Exhibition Hall
Showing 1 of 1 Streams
Keynote Plenary
16:25 - 16:30
Conference Opening Remarks
- Eden Turner - Senior Conference Producer, Informa Connect
16:30 - 16:35
Chairperson's Remarks
- Marc Bisschops, Ph.D. - Viral Vector R&D Leader, Cytiva
16:35 - 17:10
Using Monoclonal Antibodies as Antivenom
- Andreas Laustsen - Center Director & Professor, Technical University of Denmark
17:10 - 17:45
Implementing Filtration Technologies for Both Upstream and Downstream Unit Operations in Continuous Biomanufacturing
- Achraf Jazi - Product Manager, Asahi Kasei Bioprocess Europe
17:45 - 19:00
Networking Drinks Reception in Exhibit & Poster Hall
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats